Campbell & Co Investment Adviser’s PRA Health Sciences, Inc. PRAH Stock Holding History

Campbell & Co Investment Adviser’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-10,112	Closed	-$1.12M	–	609
2019 Q4	$1.12M	Buy	10,112 +3,884	+62%	+$400K	0.34%	44
2019 Q3	$618K	Sell	6,228 -1,718	-22%	-$171K	0.23%	119
2019 Q2	$788K	Buy	7,946 +1,617	+26%	+$154K	0.36%	56
2019 Q1	$698K	Buy	6,329 +2,878	+83%	+$301K	0.34%	54
2018 Q4	$351K	Sell	3,451 -3,149	-48%	-$319K	0.35%	102
2018 Q3	$727K	Buy	6,600 +2,200	+50%	+$229K	0.49%	29
2018 Q2	$411K	Buy	+4,400	New	+$379K	0.32%	103

Other funds holding PRAH

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NIPH

NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return

Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

Campbell & Co Investment Adviser's PRAH Position: Q1 2020 in Review

Campbell & Co Investment Adviser sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2020, closing a stake of 10,112 shares — an estimated $1.12M sold.

Campbell & Co Investment Adviser first reported a position in PRAH in Q2 2018 and held it in 7 quarters. The position peaked at $1.12M in Q4 2019. 301 funds tracked by Wall St. Rank hold PRAH as of Q1 2020.

Campbell & Co Investment Adviser reported no remaining PRA Health Sciences, Inc. position as of Q1 2020 after selling out during the quarter.
Campbell & Co Investment Adviser sold 10,112 PRA Health Sciences, Inc. shares in Q1 2020, an estimated $1.12M.
Campbell & Co Investment Adviser first reported a position in PRA Health Sciences, Inc. in Q2 2018 and held it in 7 quarters.
Campbell & Co Investment Adviser's PRA Health Sciences, Inc. position peaked at $1.12M in Q4 2019.
301 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2020.

Based on Campbell & Co Investment Adviser's 13F filing for Q1 2020, filed 29 Apr 2020.